Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2

Author： Brubaker Patricia L   Anini Younes  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.81, Iss.11, 2003-11, pp. : 1005-1012

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Effects of Glucagon-Like Peptide 1

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. : 97-105

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1

By Holst J.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1409-1415

Informa Healthcare

Access to resources Recommend Favorite

Glucagon and Glucagon-Like Peptide Receptors as Drug Targets

By  

Current Pharmaceutical Design, Vol. 12, Iss. 14, 2006-05 ,pp. : 1731-1750

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection

By Hölscher Christian  

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 871-882

Adis International

Access to resources Recommend Favorite

Interaction of corticotropin-releasing factor and glucagon-like peptide-1 on behaviors in chicks

By Zhang R.   Nakanishi T.   Ohgushi A.   Ando R.   Yoshimatsu T.   Denbow D.M.   Furuse M.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite